Fujian, China

Yike Li


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yike Li: Innovator in Vaccine Adjuvant Technology

Introduction

Yike Li is a prominent inventor based in Fujian, China, known for his contributions to the field of pharmaceutical technology. He has been instrumental in developing innovative vaccine adjuvants that enhance the efficacy of vaccines. With a total of 2 patents, his work is paving the way for advancements in immunology.

Latest Patents

Yike Li's latest patents include the "Preparation of zinc zoledronate micro-nanoparticle adjuvant and use thereof as vaccine adjuvant." This invention discloses a zinc zoledronate micro-nanoparticle adjuvant that contains zinc and zoledronic acid, with optional phosphate and aluminum. The preparation method involves mixed precipitation on a soluble salt solution containing zinc ions, zoledronic acid, and sodium hydroxide. This adjuvant can be utilized in vaccine preparation.

Another significant patent is the "Preparation of zinc risedronate micro/nano adjuvant and use thereof as vaccine adjuvant." This invention relates to a zinc risedronate micro/nano adjuvant with a sustained-release function, formed by mineralization of zinc ions and risedronic acid. It also includes a method for preparing the adjuvant and its use in vaccine compositions.

Career Highlights

Yike Li has worked with notable institutions such as Xiamen University and Xiamen Innovax Biotech Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical technology and vaccine development.

Collaborations

Yike Li has collaborated with several professionals in his field, including Xiaofen Huang and Siyi Chen. These collaborations have further enriched his research and development efforts in vaccine adjuvant technology.

Conclusion

Yike Li's innovative work in vaccine adjuvants demonstrates his commitment to advancing pharmaceutical technology. His patents reflect significant contributions to the field, which may lead to improved vaccine efficacy in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…